Pi Therapeutics, a company dedicated to the development of novel modulators of protein degradation for cancer has announ...
Within the next ten years, up to six new drugs are projected to be approved for the treatment of chronic hepatitis B vir...
The partner of CStone Pharmaceuticals, Agios Pharmaceuticals has announced that the global Phase 3 ClarIDHy trial o...
Takeda Pharmaceutical Company Limited has announced further results from the Phase 3b head-to-head VARSITY study, w...
Growing scientific evidence supports liquid biopsy as a valuable tool for monitoring treatment response in patients with...
Ping An Insurance Company of China has announced that its technology arm, Ping An Technology, has c...
Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a ...
WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring and neuromodulation,...
AstraZeneca announced positive results from the phase III ASCEND trial of Calquence (acalabrutinib) in previously-treate...
Daiichi Sankyo Company, Limited (Daiichi Sankyo) and AstraZeneca have announced positive topline results for the pivotal...
Innovent Biologics and Eli Lilly and Company has jointly announced that IBI301, a recombinant human-mouse...
US based VolitionRx Limited has announced that it has added to its extensive clinical trial programme with the execution...
Asia Pacific is expected to become the destination of choice for clinical trials due to its fast-growing pharmaceutical ...
Tessa Therapeutics, a clinical-stage cell therapy company focused on autologous and allogeneic therapies for a wide rang...
Sinovant Sciences has announced that its Clinical Trial Application (CTA) for derazantinib has been accepted by the...
ACADIA Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative ...
Collaborative Medicinal Development LLC (CMD) is a privately-held biopharmaceutical company developing innovative therap...
Zydus Cadila, an innovation-driven, global pharmaceutical company, announced the Phase III trials of Desidustat, an Inve...
